RNTX
Rein Therapeutics
RNTX
RNTX
17 hedge funds and large institutions have $957K invested in Rein Therapeutics in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less capital invested
Capital invested by funds: $2.37M → $957K (-$1.41M)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$172K | |
| 2 | +$86.3K | |
| 3 | +$21K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$368K | |
| 3 | -$91K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$67K |
| 5 |
VF
Virtu Financial
New York
|
-$45K |